查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2005047

兽医感染疾病诊断市场：2026-2032年全球市场预测（依疾病、产品、给药方式、目标动物及应用划分）

Veterinary Infectious Disease Diagnostics Market by Disease Category, Product, Offering, Animal Type, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，兽医感染疾病诊断市场价值将达到 24.2 亿美元，到 2026 年将成长至 26.2 亿美元，到 2032 年将达到 43.3 亿美元，复合年增长率为 8.65%。

主要市场统计数据
基准年 2025 24.2亿美元
预计年份：2026年 26.2亿美元
预测年份 2032 43.3亿美元
复合年增长率 (%) 8.65%

兽医感染疾病诊断领域取得变革性进展及其对动物健康管理的影响的舞台。

兽医感染疾病诊断技术的进步正在重塑临床医生和研究人员管理动物健康的方式。尖端分子技术、快速就地检验和数据驱动的决策支援工具的结合，使得在伴侣动物和生产动物中更早、更准确地检测病原体威胁成为可能。因此，兽医现在能够更积极主动地进行干预，降低发病率和死亡率，同时最大限度地减少通用感染疾病的风险。

重新定义兽医感染疾病诊断的前景，并阐明将推动整个动物健康领域临床创新的突破性变革。

在兽医诊断领域，几个关键趋势正在汇聚，重新定义感染检测和监测的模式。其中最重要的是，检测方式正从单一分析物检测转向多重检测和综合征检测。这些进步使得同时检测多种病原体成为可能，从而缩短诊断时间，并提供更全面的临床资讯。分析仪器的微型化进一步加速了这项变革，使得携带式设备能够在野外和偏远诊所部署使用。

对 2025 年美国新关税对兽医感染疾病诊断供应链和创新的影响进行全面评估。

2025年起对美国兽用诊断产品进口征收的关税，为全球供应链带来了新的复杂性。试剂、检测套组和分析仪器组件的供应商正面临成本上涨的困境，其影响也开始波及价格结构。这些额外的成本迫使製造商和终端用户重新评估其筹资策略和库存管理通讯协定。

对兽医感染疾病诊断类别和产品进行全面的細項分析，以确定关键驱动因素和成长模式。

兽医感染疾病诊断市场可透过多个关键观点进行分析，从而揭示其独特的驱动因素和新兴机会。有鑑于病原体的多样性，对于钩端螺旋体病和布氏桿菌症等细菌感染疾病，需要快速确诊的检测方法；而对于犬细小病毒和犬瘟热等病毒感染，高通量分子检测则十分有效。真菌病原体虽然较少见，但需要专门的培养和血清学平台；寄生虫感染则需要高灵敏度的免疫检测来检测循环抗原。

对主要全球市场中已开发市场和新兴市场兽医感染疾病诊断的未来发展进行地理格局和区域趋势分析。

兽医感染疾病诊断的区域趋势受畜牧模式、农业实践和法规结构差异的影响。在美洲，美国和加拿大凭藉其强大的研究基础设施和完善的兽医网络，在技术应用方面处于领先地位。随着畜牧业的扩张和伴侣动物照护的日益精细化，拉丁美洲市场正在迅速崛起，推动了对经济高效的诊断解决方案的需求。

分析推动兽医感染疾病诊断领域突破性进展并增强市场竞争力的关键创新者和策略合作伙伴关係。

兽医感染疾病诊断领域的创新由少数几家主要企业推动，这些企业将卓越的研发能力与策略合作伙伴关係相结合。一群市场领导者专注于开发综合分子诊断平台，这些平台能够以高分析灵敏度检测多种病原体。这些平台与专为现场使用而设计的试剂组相辅相成，从而能够将实验室能力无缝部署到农场和兽医诊所环境中。

产业相关人员应实施的目标策略和营运框架，以加速兽医诊断领域的成长并应对该领域的挑战。

寻求掌握新机会的产业领导者应优先投资能够检测多种病原体的下一代分子诊断平台。扩大内部研发能力或与专业生技公司建立合作关係，可缩短产品上市时间，并确保其与临床需求保持一致。此外，透过本地化生产实现采购多元化并增强供应链韧性，有助于降低关税和物流风险。

本文概述了一种严谨的调查方法，该方法结合了定量分析和专家检验，以确保在兽医感染疾病诊断领域获得可靠的知识。

本报告的研究结果基于严谨的调查方法，该方法融合了定量分析和专家检验。作为市场认知基础的二手研究，使用了同行评审的学术期刊、公共卫生资料库、监管文件和技术白皮书。这种全面的文献综述确保了对新兴趋势和技术突破的透彻理解。

本文总结了感染疾病兽医诊断生态系统发展过程中决策面临的关键见解和策略挑战。

总而言之，在技术创新、法规演变和贸易政策转变的驱动下，兽医感染疾病诊断市场目前正经历重大变革时期。多重分子检测、照护现场设备和数据分析平台的兴起正在重塑诊断流程，从而能够对伴侣动物和生产动物进行更积极主动的疾病管理。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依疾病分类的兽医感染疾病诊断市场

  • 细菌
  • 真菌
  • 寄生虫
  • 病毒性的

第九章：兽医感染疾病诊断市场：依产品划分

  • 消耗品
    • 试剂
    • 检测套组
  • 设备/分析仪
    • 临床化学分析仪
    • 血液检测设备
    • 免疫诊断分析仪
    • 分子诊断分析仪

第十章：兽医感染疾病诊断市场：依产品/服务分类

  • 硬体
  • 服务
  • 软体

第十一章：兽医感染疾病诊断市场：依动物类型划分

  • 伴侣动物
    • 猫
    • 狗
  • 牲畜和生产动物
    • 牛
    • 山羊
    • 家禽
    • 羊
    • 猪

第十二章 兽医感染疾病诊断市场：依最终用途划分

  • 院内检测设施
    • 动物收容所
    • 宠物饲主
  • 研究所
  • 兽医医院和诊所

第十三章 兽医感染疾病诊断市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 兽医感染疾病诊断市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 兽医感染疾病诊断市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国兽医感染疾病诊断市场

第十七章：中国兽医感染疾病诊断市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agrolabo SpA
  • Antech Diagnostics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biogal Galed Labs
  • BioMerieux SA
  • BioNote, Inc.
  • Demeditec Diagnostics GmbH
  • DEXX Laboratories Inc.
  • Eurofins Technologies
  • Fassisi GmbH
  • FUJIFILM Holdings Corporation
  • IDEXX Laboratories, Inc.
  • IDvet
  • Mars, Incorporated
  • Merck & Co., Inc.
  • Neogen Corporation
  • Nisseiken Co., Ltd
  • Qiagen NV
  • Randox Laboratories, Ltd.
  • Shenzhen Bioeasy Biotechnology Co., Ltd.
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • SKYER, Inc.
  • Skyla Corporation
  • Thermo Fisher Scientific Inc.
  • Vimian Group AB
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-742BD5184F0A

The Veterinary Infectious Disease Diagnostics Market was valued at USD 2.42 billion in 2025 and is projected to grow to USD 2.62 billion in 2026, with a CAGR of 8.65%, reaching USD 4.33 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.42 billion
Estimated Year [2026] USD 2.62 billion
Forecast Year [2032] USD 4.33 billion
CAGR (%) 8.65%

Setting the Stage for Transformative Advances in Veterinary Infectious Disease Diagnostics and Their Impact on Animal Health Management

Advances in veterinary infectious disease diagnostics are reshaping the way clinicians and researchers approach animal health management. The convergence of cutting-edge molecular techniques, rapid point-of-care testing, and data-driven decision support tools enables earlier detection and more accurate identification of pathogenic threats across both companion and production species. Consequently, veterinary professionals are now equipped with the capacity to intervene proactively, reducing morbidity and mortality while also minimizing the risk of zoonotic transmission.

Over the past decade, growing awareness of One Health principles has intensified collaboration between animal and human health sectors. This synergy not only fosters shared learning but also drives investment in diagnostic innovation that benefits both fields. As a result, novel platforms have emerged that integrate multiplex assay functionality with digital connectivity, allowing real-time monitoring and seamless data exchange. In turn, these developments support epidemiological surveillance programs and targeted treatment protocols.

Moreover, regulatory frameworks are evolving in response to the accelerated pace of technological advancement. Harmonization efforts among global agencies aim to streamline approval processes for novel diagnostic reagents and platforms while ensuring robust validation standards. In parallel, supply chain resilience is becoming an imperative as stakeholders confront disruptions related to geopolitical tensions, trade policies, and logistic constraints. By anticipating these challenges and embracing adaptive strategies, practitioners and industry leaders can sustain innovation pipelines and deliver solutions that address the most pressing infectious disease threats in veterinary medicine.

Uncovering the Revolutionary Shifts Redefining the Veterinary Infectious Disease Diagnostics Landscape and Driving Clinical Innovation Across Animal Health Sectors

Across the veterinary diagnostics sector, several pivotal trends are converging to redefine the infection detection and monitoring paradigm. Foremost among these is the transition from single-analyte assays toward multiplex and syndromic panels. By enabling simultaneous detection of multiple pathogens, these advancements reduce time to diagnosis and provide a more comprehensive clinical picture. This transformative shift is further amplified by the miniaturization of analytic hardware, which supports deployment of portable devices in field settings and remote clinics.

Equally significant is the rise of molecular isothermal amplification techniques, which offer robust sensitivity comparable to polymerase chain reaction without the need for complex thermal cycling. Coupled with smartphone integration and cloud-based data management, point-of-care diagnostics are becoming increasingly user-friendly and accessible. As a result, diagnostic workflows are transitioning from centralized laboratories to decentralized frameworks, empowering veterinarians to make rapid, evidence-based decisions at the site of care.

In parallel, the incorporation of advanced data analytics and machine learning is unlocking novel insights from diagnostic outputs. Algorithms trained on extensive historical datasets can now predict outbreak patterns, guide antimicrobial stewardship, and optimize herd health management. Furthermore, collaborations between diagnostic developers and academic institutions are accelerating the translation of cutting-edge biomarkers into practical assays. Together, these shifts signal a new era in which diagnostic innovation and digital transformation converge to enhance animal welfare, protect public health, and drive economic value across the veterinary ecosystem.

Transitioning from traditional workflows, the procurement and supply chain models are adapting to support just-in-time delivery of critical reagents and consumables. Manufacturers are exploring localized distribution centers and additive manufacturing techniques to reduce lead times and mitigate logistics risks. Alongside these operational changes, regulatory agencies are updating guidelines to accommodate novel diagnostic modalities and digital health integrations. The combined effect of these shifts is a more responsive, resilient landscape that can adapt to emergent disease challenges with greater agility.

Evaluating the Comprehensive Effects of Newly Implemented United States Tariffs in 2025 on the Veterinary Infectious Disease Diagnostics Supply Chain and Innovation

The implementation of United States tariffs on veterinary diagnostic imports in 2025 has introduced a new layer of complexity to the global supply chain. Suppliers of reagents, test kits, and analyzer components are facing elevated costs that have begun to ripple through pricing structures. These added expenses place pressure on both manufacturers and end-use facilities to reevaluate procurement strategies and inventory management protocols.

In response to higher duty rates, several stakeholders are pursuing alternative sourcing avenues. Regional distribution networks are expanding their footprint to mitigate reliance on tariff-affected imports. At the same time, domestic producers are exploring strategic partnerships with component manufacturers to localize critical reagent production. This trend underscores the importance of a resilient supply ecosystem capable of withstanding regulatory and economic headwinds.

Moreover, increased input costs are incentivizing end users to optimize diagnostic workflows for cost efficiency. Veterinary hospitals and research laboratories are negotiating bundled service agreements and exploring reagent rental models to balance capital expenditure with operational flexibility. These adaptations reflect a broader shift toward collaborative purchasing and shared resource frameworks.

Looking ahead, industry participants anticipate that evolving trade policies will remain a defining factor in strategic decision-making. Companies that invest in agile manufacturing, robust supplier diversification, and proactive policy engagement will be best positioned to sustain growth. Ultimately, the capacity to navigate tariff dynamics will determine the long-term viability of new diagnostic platforms and their adoption across various veterinary settings.

Unveiling Comprehensive Segmentation Insights Revealing Critical Drivers and Growth Patterns Across Diverse Veterinary Infectious Disease Diagnostic Categories and Products

The veterinary infectious disease diagnostics market can be examined through several critical lenses that reveal unique drivers and emerging opportunities. When considering pathogen diversity, bacterial infections such as leptospirosis and brucellosis demand rapid confirmatory testing, while viral threats like parvovirus and canine distemper benefit from high-throughput molecular assays. Fungal pathogens, although less prevalent, necessitate specialized culture and serology platforms, and parasitic infestations require sensitive immunoassays to detect circulating antigens.

Turning to product offerings, consumables represent a significant share of laboratory expenditure, particularly the reagents and test kits that support both traditional and molecular workflows. Instruments and analyzers span a wide spectrum from clinical chemistry devices and hematology counters to point-of-care immunodiagnostic readers and advanced molecular diagnostic platforms. Each category carries distinct cost-benefit considerations related to throughput, ease of use, and maintenance requirements.

Within the framework of solution delivery, hardware investments in next-generation sequencers and multiplex analyzers are complemented by software solutions that enable data analytics and remote monitoring. Service agreements, including preventive maintenance and technical support, serve as a backbone for instrument uptime and operator proficiency, creating recurring revenue streams that underpin long-term vendor relationships.

Animal type segmentation further refines market focus. Companion animals such as cats and dogs benefit from rapid in-clinic assays that drive pet owner satisfaction, while livestock testing protocols for cattle, swine, and poultry emphasize herd-level health and productivity metrics. End users vary from in-house testing facilities at research institutions and shelters to dedicated veterinary hospitals and clinics. Each segment exhibits distinct adoption curves governed by budgetary constraints, throughput expectations, and regulatory compliance requirements.

Analyzing Geographical Patterns and Regional Dynamics Shaping the Future of Veterinary Infectious Disease Diagnostics across Established and Emerging Economies in Key Global Markets

Regional dynamics in veterinary infectious disease diagnostics are shaped by variations in animal ownership patterns, agricultural practices, and regulatory frameworks. In the Americas, the United States and Canada lead in technological adoption, leveraging strong research infrastructures and well-established veterinary networks. Markets in Latin America are emerging rapidly as livestock production expands and companion animal care becomes more sophisticated, driving demand for cost-effective diagnostic solutions.

Europe, Middle East & Africa present a diverse landscape. Western European countries benefit from harmonized regulations under the European Medicines Agency, facilitating cross-border distribution of advanced diagnostic kits and analyzers. In contrast, markets in the Middle East and Africa are characterized by fragmented regulatory environments and infrastructural constraints, which create opportunities for portable, robust testing platforms and capacity-building partnerships.

The Asia-Pacific region is distinguished by its high livestock density and growing companion animal segment in countries such as China, India, and Australia. Government initiatives promoting animal health and food safety have spurred investments in large-scale diagnostic laboratories. Meanwhile, smaller clinics are adopting point-of-care tests to meet increasing demand for rapid turnarounds, particularly in remote and rural geographies.

Across all regions, emerging economies are prioritizing investments in local production capabilities to reduce dependency on imports and improve cost resilience. Data sharing agreements and collaborative surveillance programs are on the rise, fostering a more integrated global ecosystem for disease monitoring and outbreak preparedness.

Profiling Leading Innovators and Strategic Partnerships Driving Breakthroughs in Veterinary Infectious Disease Diagnostics and Enhancing Market Competitiveness

Innovation in veterinary infectious disease diagnostics is propelled by a handful of leading companies that combine research excellence with strategic alliances. One category of market leaders has focused on developing comprehensive molecular diagnostic platforms that deliver multiplex pathogen detection with high analytical sensitivity. These platforms are complemented by reagent kits designed for field use, enabling seamless translation of laboratory capabilities into on-farm and in-clinic settings.

Another cohort of innovators has prioritized digital integration. By embedding connectivity features into analyzers and employing cloud-based data management, these firms offer real-time result sharing and remote monitoring services. Such capabilities support centralized oversight of multi-site operations, facilitating consistent quality standards and streamlined troubleshooting.

Strategic partnerships between diagnostic developers and academic or governmental research institutes have accelerated the validation of novel biomarkers and the launch of next-generation tests. Collaborative consortia that focus on zoonotic disease surveillance bring together cross-sector stakeholders to co-create solutions that address unmet needs. In parallel, service-oriented business models-featuring comprehensive maintenance agreements and user-training programs-have become critical differentiators that promote long-term customer loyalty.

Looking ahead, agile market entrants are expected to leverage modular platform designs, customizable workflows, and subscription-based software licensing to enhance flexibility and reduce total cost of ownership. These strategies reflect an industry-wide emphasis on delivering end-to-end solutions that align with the evolving demands of veterinary practitioners and research laboratories alike.

Implementing Targeted Strategies and Operational Frameworks for Industry Stakeholders to Accelerate Growth and Navigate Challenges in Veterinary Diagnostics

Industry leaders seeking to capitalize on emerging opportunities should prioritize investments in next-generation molecular platforms capable of multiplex pathogen detection. By expanding internal R&D capabilities or forging alliances with specialized biotechnology firms, they can accelerate time to market and ensure alignment with clinical needs. In addition, strengthening supply chain resilience through diversified sourcing strategies and localized manufacturing will mitigate tariff and logistics risks.

Digital transformation should be advanced through the integration of software solutions that enable remote monitoring, data analytics, and predictive modeling. Piloting these technologies in select sites will provide valuable user feedback and inform scalable deployment plans. Concurrently, engagement with regulatory authorities and participation in harmonization initiatives will streamline approval pathways for novel diagnostics and foster a more predictable innovation landscape.

Cross-sector collaboration represents another critical success factor. By partnering with academic laboratories, public health agencies, and agricultural stakeholders, organizations can access unique datasets and validate emerging biomarkers under real-world conditions. Establishing formal consortia for zoonotic disease surveillance also enhances market credibility and opens new channels for funding and co-development.

Finally, workforce development must be addressed through targeted training programs that elevate operator proficiency and technical expertise. Investing in customer education-via workshops, online modules, and certification tracks-reinforces product value propositions and drives sustained market engagement.

Outlining Rigorous Research Methodology Combining Quantitative Analysis and Expert Validation to Ensure Robust Insights into Veterinary Infectious Disease Diagnostics

This report's findings are grounded in a rigorous research methodology that integrates both quantitative analysis and expert validation. Secondary research formed the foundation of market understanding, drawing on peer-reviewed journals, public health databases, regulatory filings, and technical white papers. This comprehensive literature review ensured that emerging trends and technological breakthroughs were thoroughly captured.

Primary research was conducted through in-depth interviews with key opinion leaders, including veterinary practitioners, laboratory directors, academic researchers, and industry executives. These conversations provided real-world perspectives on diagnostic adoption drivers, workflow inefficiencies, and unmet clinical needs. In addition, targeted surveys of end users were deployed to quantify adoption levels, budgetary constraints, and purchasing preferences across different segments.

Data triangulation techniques were applied to reconcile findings from multiple sources and enhance overall accuracy. Preliminary conclusions were subjected to a validation round with an advisory panel composed of subject matter experts, who provided critical feedback on assumptions and scenario analyses. This iterative review cycle helped refine market segmentation frameworks and ensure robustness of regional and regulatory insights.

Quality control measures, including cross-dataset consistency checks and hypothesis testing, were implemented throughout the research process. The result is a set of actionable insights and strategic recommendations that reflect both empirical data and frontline expertise, empowering decision-makers to navigate the dynamic landscape of veterinary infectious disease diagnostics with confidence.

Summarizing Key Insights and Strategic Imperatives to Inform Decision Making in the Evolving Veterinary Diagnostics Ecosystem for Infectious Diseases

In summary, the veterinary infectious disease diagnostics market is undergoing a period of profound transformation driven by technological innovation, regulatory evolution, and shifting trade policies. The rise of multiplex molecular assays, point-of-care devices, and data analytics platforms is redefining diagnostic workflows and enabling more proactive disease management across both companion and production animals.

Tariff adjustments in 2025 have underscored the necessity of supply chain resilience and strategic procurement models. Organizations that invest in localized manufacturing, supplier diversification, and collaborative purchasing arrangements will be best prepared to navigate cost pressures and maintain service continuity. Meanwhile, segmentation analysis highlights distinct adoption patterns across disease categories, product typologies, and end-use settings, guiding targeted go-to-market strategies.

Regional dynamics further illustrate the importance of aligning product portfolios with local infrastructure, regulatory requirements, and customer needs. From the technologically advanced markets of North America and Western Europe to the fast-growing economies of Asia-Pacific and Latin America, opportunities abound for agile companies that tailor solutions effectively.

Ultimately, success in this evolving ecosystem will hinge on integrated strategies that combine innovation in hardware, software, and services with strong stakeholder partnerships and robust market intelligence. Decision-makers who leverage these insights and proactively implement recommended actions will secure a leadership position in the next chapter of veterinary diagnostics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Infectious Disease Diagnostics Market, by Disease Category

  • 8.1. Bacterial
  • 8.2. Fungal
  • 8.3. Parasitic
  • 8.4. Viral

9. Veterinary Infectious Disease Diagnostics Market, by Product

  • 9.1. Consumables
    • 9.1.1. Reagents
    • 9.1.2. Test kits
  • 9.2. Instruments/Analyzers
    • 9.2.1. Clinical chemistry analyzers
    • 9.2.2. Hematology analyzers
    • 9.2.3. Immunodiagnostic analyzers
    • 9.2.4. Molecular diagnostic analyzers

10. Veterinary Infectious Disease Diagnostics Market, by Offering

  • 10.1. Hardware
  • 10.2. Services
  • 10.3. Software

11. Veterinary Infectious Disease Diagnostics Market, by Animal Type

  • 11.1. Companion Animals
    • 11.1.1. Cat
    • 11.1.2. Dog
  • 11.2. Livestock/Production Animals
    • 11.2.1. Cattle
    • 11.2.2. Goats
    • 11.2.3. Poultry
    • 11.2.4. Sheep
    • 11.2.5. Swine

12. Veterinary Infectious Disease Diagnostics Market, by End Use

  • 12.1. In-House Testing Facilities
    • 12.1.1. Animal Shelters
    • 12.1.2. Pet Owners
  • 12.2. Research Laboratories
  • 12.3. Veterinary Hospitals & Clinics

13. Veterinary Infectious Disease Diagnostics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Veterinary Infectious Disease Diagnostics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Veterinary Infectious Disease Diagnostics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Veterinary Infectious Disease Diagnostics Market

17. China Veterinary Infectious Disease Diagnostics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agrolabo S.p.A.
  • 18.6. Antech Diagnostics, Inc.
  • 18.7. Bio-Rad Laboratories, Inc.
  • 18.8. Biogal Galed Labs
  • 18.9. BioMerieux S.A.
  • 18.10. BioNote, Inc.
  • 18.11. Demeditec Diagnostics GmbH
  • 18.12. DEXX Laboratories Inc.
  • 18.13. Eurofins Technologies
  • 18.14. Fassisi GmbH
  • 18.15. FUJIFILM Holdings Corporation
  • 18.16. IDEXX Laboratories, Inc.
  • 18.17. IDvet
  • 18.18. Mars, Incorporated
  • 18.19. Merck & Co., Inc.
  • 18.20. Neogen Corporation
  • 18.21. Nisseiken Co., Ltd
  • 18.22. Qiagen N.V.
  • 18.23. Randox Laboratories, Ltd.
  • 18.24. Shenzhen Bioeasy Biotechnology Co., Ltd.
  • 18.25. Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • 18.26. SKYER, Inc.
  • 18.27. Skyla Corporation
  • 18.28. Thermo Fisher Scientific Inc.
  • 18.29. Vimian Group AB
  • 18.30. Virbac S.A.
  • 18.31. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 200. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 202. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 203. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 204. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 205. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 206. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 208. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 233. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 235. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 236. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 237. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 238. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 239. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 241. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 242. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 243. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 244. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 246. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 247. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 248. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 249. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 250. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 252. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 253. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA VETERINARY INFECTIOUS DISEASE